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A B S T RA C T 1251-angiotensin II (AII) specifically bound to rat glomerular basement membrane (GBM). The kinetics of binding were similar to those obtained with the total glomeruli. The apparent dissociation constant was close to 50 pM with both preparations. The number of sites related to the amount of protein was two times greater with GBM than with total glomeruli. Since the amount of GBM protein extracted from a given amount of glomerular protein was about 10%, it was possible to estimate the share of the GBM binding sites for AII as representing 20% of the total number present in the entire glomerulus. Binding studies at equilibrium as a function of 1251-AII concentration and competitive binding experiments suggested either multiplicity of the binding sites or cooperativity in the binding reaction. Degradation of 1251-AII in the presence of GBM was slight and did not increase with time. The difference in the degrees of degradation of 1251_ All was too small to account for the observed difference in binding when the results obtained with GBM and isolated glomeruli preparations were compared. 1251-AII binding to GBM was increased after treatment of these membranes with collagenase, slightly diminished with neuraminidase, and almost completely abolished with trypsin suggesting the proteic naLture of the receptor. '251-AII binding to GBM was diminished after incubation of GBM with anti-GBM antibodies as a result of a decrease in the number of binding sites. '25I-AII binding was even more diminished in preparations of glomeruli isolated from rats passively immunized with anti-GBM antibodies when compared with glomeruli from control animals. This resulted from both smaller affinity for AII and decrease in the number of the binding sites. The present data provides evidence for specific binding sites for All localized on GBM.
INTRODUCTION
It has been clearly shown that Angiotensin II (All)' labeled either with 1251_ (1, 2) or [3H ] (2) binds specifically to glomenrli obtained from rat kidney cortex. Fturthermore the mtultiplateaui-cturve obtained when specific binding is plotted against the concentration of All in the medium (2) (1, 4) . Such an effect may be mediated by activation, perhaps via the AII receptor, of the contractile properties of the mesangial cells (5) . Very recent evidence suggests yet other potential roles for AII on glomerular permeability. Blantz et al. (6) with micropuncture studies in the rat observed that All produced a fall in single nephron glomerular filtration rate related to a decrease in total glomerular permeability. This decrease was considerably greater than expected on the basis of a reduction in the glomerular surface area (associated to the decrease in capillary radius) and therefore suggested a change in local capillary permeability to water. Eisenbach et al. (7) have also shown Hunter and Greenwood (8) . Labeled and unlabeled molecules were separated by using polyacrylamide gel electrophoresis according to Corvol et al. (9) . The specific activity of the labeled hormone, assessed by radioimmunoassay as previously described (1) was 2,000 mCi/,umol. This is close to the theoretical value corresponding to one atom iodine per molecule. The following chemicals were purchased from the commercial sources indicated: neuraminidase (from Vibrio cholerae, 500 U/ml) and trypsin (10, to the technique of Fong and Drummond (10) with minor modifications. In short, cortex from four kidneys was dissected and minced to a paste-like consistency. The homogenate was then gently pushed through a 106 mesh screen and suspended in 10 ml of 0.07 M phosphate buffer, pH 7.5. The suspension was passed through a 25 gauge needle and then centrifuged at 120 g for 90 s. The supemate was discarded and the pellet resuspended in the same buffer solution, passed again through the needle, and centrifuged. This operation was repeated five times to obtain the final glomerular preparation. GBM were purified from the isolated glomeruli according to the technique of Blau and Michael (11) ; isolated glomeruli were sonicated with a Branson sonifer (Branson Sonic Power Co., Danbury, Conn., model W185 D) at position 5 for 3 min. The sediment of washed GBM obtained at the end of the purification process was either lyophilized and stored for further immunization of rabbits or resuspended in 1.0 M sodium chloride and immediately used. An aliquot of sonicated glomeruli was conserved for comparison with GBM in the binding studies of AII. The protein in a given amount of isolated glomeruli and in the corresponding purified GBM was determined according to Lowry et al. (12) . This allowed the calculation of the yield of purification of GBM which was about 10% (Table I) . DNA (13) and phospholipids (14) were measured in both preparations and related to the dry weight. Amino-acid analysis was also performed with a Technicon (Technicon Instruments Corp., Tarrytown, N. Y.) amino-acid analyzer on protein hydrolysates (6 N HCl for 24 h at 110°C) according to the method of Spackman et al. (15) . 3 OH and 4 OH-proline were separately measured with a Beckman (multichrom) analyzer according to Benson and Patterson (16) . The ratio of the concentrations of these different substances in GBM and isolated glomeruli, respectively, was used to appreciate GBM purification.
Anti-GBM antibodies were raised in rabbits. Approximately 10 mg (dry weight) of GBM in 0.5 ml of phosphate buffered saline: Na H2 P04, 2.4 mM; Na2 H P04, 7.6 mM; Na Cl, 126 mM mixed with an equal volume of complete Freund's adjuvant was injected three times at 1-wk interval into each of four adult male rabbits. These aniimals received similultaneously 0.2 ml of Bordetella pertussis vaccine (Parke Davis and Co., Detroit, Mich.).Rabbits were then repeatedly bled, and sera were tested for anti-GBM antibody by the indirect immunofluoreseence technique. Kidney sections fromii normncal rats were first incubated with progressive dilutions of rabbit antiserum, washed, and then incubated in the presenice of fluorescent antirabbit IgG. The titer of the rabbit anitisertimii was the greatest dilution providing a positive immunofluorescence and was 1/400 for the antiserum selected. Immuni e rabbit gammaglobulin was partially purified from the total serum by precipitation with 50% saturated ammonium sulfate, redissolved in phosphate buffered saline, and dialyzed against repeated changes of this buffer during 24 (1) that the amount of AII bound to isolated glomeruli was linearly related to the amount of glomerular protein over the range of protein concentrations studied (100-500 ,ug/ml). Similar linearity was also obtained when AII bound to GBM was plotted against the amount of GBM protein (r = +0.995).
In other experiments, GBM "were exposed first to anti-GBM antibodies, washed extensively, and then incubated with 125I-AII. Precisely, 0.4 ml of GBM suspension (2.2 mg of protein/ml) was centrifuged and the corresponding pellet incubated in a Dubnoff incubator with continuous agitation during 1 h at 4°C with an equal volumt of phosphate buffered saline containing partially purified IgG (20 mg/ml) obtained from either immunized or control rabbits. The preparation was then centrifuged at 120 g for 15 min. After the supernate was discarded, the pellet was washed twice with distilled water, resuspended in 1.0 M sodium chloride, and used in binding experiments in the same conditions as stated above.
In vivo binding studies. In each of these experiments two rats were injected intravenously with 60 mg (3 ml) of IgG partially purified from the serum of immunized rabbits and two other rats with the same amount of partially purified IgG from control rabbits. 16 Spontaneous degradation of '25I-AII. Degradation of 125I-AII present in the incubation milieu was studied with polyacrylamide gel electrophoresis and binding to an excess of specific antibodies. Polyacrylamide gel electrophoresis was performed according to Corvol et al. (9) . Undamaged hormone was estimated as the peak of radioactivity corresponding to 125I-AII Rf. Binding of 125I-AII to an excess of specific antibody was measured after a 16-h incubation. This antibody had been raised in the rabbit and was used at a final dilution of 1/400 which produced binding of more than 90% of the total radioactivity. Free and bound radioactivities were separated with the charcoal dextran method. In each experiment, appropriate controls were prepared which were identical except that isolated glomeruli or GBM were omitted. These controls represented 100% of the hormone available for degradation. To evaluate hormone degradation, results were expressed as percentage of control remaining after the same period of incubation. Nature of the receptor. GBM (1 mg of protein/ml) were incubated with various enzymes during 30 min in 1.0 M NaCl. Final concentrations of the enzymes were 200 ,g/ml for collagenase, 2,500 ,ug/ml for trypsin, and 12.5 IU/ml for neuraminidase. Temperature was 37°C for the first and 300C for the latter two. After incubation the tubes were centrifuged (5 min at 500 g) and the pellet washed once with 1.0 M NaCl. Treated and control membranes (100 u±g of protein) were then added to tubes containing 100 pM 125I-AII and incubated during 20 min in the same conditions as stated above. In the trypsin studies. parallel experiments were performed: soybean trypsin inhibitor (2,500 ,ug/ml) was added to either treated or control membranes to inhibit any trace of trypsin left after washing which could degrade the hormone.
RESULTS
Tests of validity ofpurification of GBM. The preparation of GBM was considered as purified from the following tests. Firstly, electron microscopy examination ( Fig. 2) showed that GBM were free of cells or recognizable fragments but small amounts of cellular debris were seen, probably trapped between the isolated membranes during centrifugation. Since the preparation of isolated glomeruli was free of Bowman's capsule, GBM can be considered as only coming from the capillary walls. Secondly, chemical markers were assayed in both preparations (Table II) and the results obtained were close or similar to published biochemical data on GBM (18, 19) . The concentration of DNA considered as a nucleus marker was 103 t 15 ug/mg of dry weight in the starting preparation of isolated glomeruli and equal to or below the lower limit of detection in the GBM preparation. Similarly, the concentration of phospholipids which are a cell membrane marker was 52.0±3. 4 ,ug/mg of dry weight in the glomerular preparation and 11.2±1.2 ug/mg of dry weight in the GBM preparation. The latter value is close to that found by Sato et al. (18) and smaller than that observed by Westberg and Michael (19) in human GBM. The ratio of purification of GBM was in the same range as in the latter study. Amino-acid analysis showed that GBM contained higher concentrations of hydroxyproline, hydroxylysine, and glycine than isolated glomeruli (b). (18, 19) . The enrichment factors were in agreement and Michael (19 protein was clearly higher in the preparation ofpurified GBM. Dissociation of the bound hormone was produced in both preparations by the addition of 50 ,uM unlabeled AII, and at any time, the residual bound hormone was greater with the preparation of GBM. This higher binding of AII to GBM was not due to a greater degradation of 125I-AII in the incubation milieu since bound hormone was expressed as the percentage of the concentration of undegraded hormone in the milieu. This concentration at each time was obtained by multiplying the total radioactivity concentration by the corresponding fraction of intact hormone measured in parallel experiments. The latter mode of expression allowed the correction of the data according to the different rates of degradation of 125I_ AII in the presence of GBM or isolated glomeruli (see below: degradation studies). 1251-AII binding was also measured as a function of hormonal concentration after a 20-min incubation. An apparent nonlinear curve was obtained both with GBM and isolated glomeruli preparations for concentrations of 125j-AII ranging from 50 pM to 4 nM (Fig. 4a) . It could reflect a cooperative model in which the affinity of binding is modified with the degree of occupancy of the receptor sites. Binding was clearly higher for all points of the cturve with the GBM preparation. Inhibition of binding of 1251-AII by uinlabeled All was compared in both preparations. As shown in Fig. 5a , dilution of 1251-AII (50 pM) with increasing concentrations of unlabeled AII above 0.01 ng/ml (10 pM) decreased the percentage bound of the total hormone in both preparations. As indicated for the time-course studies, total hormone, at each concentration of unlabeled hormone, was corrected for degradation measured in parallel experiments. At concentrations of native AII ranging between 0 and 1 ,ug/ml, binding was clearly higher in the GBM preparation, but the difference between the two curves diminished progressively when the concentration of unlabeled AII increased. The indexes of binding were calculated from time-course studies as previously described (1). the regression line corresponding to the six greater concentrations of bound hormone was calculated and subtracted from the other experimental points to obtain the greater slope line. The two greater slope lines corresponding to GBM and isolated glomeruli, respectively, were considered as reflecting high affinity groups of sites. The linearity of these two curves was confirmed by the values of the correlation coefficients (-0.940 and -0.920 for GBM and isolated glomeruli, respectively) which were close to unity. Asp')AII was slightly less active whereas the activity of the 3-8 hexapeptide (Des Asp', Des Arg2)AII was less than half that of the intact octapeptide at the greatest concentration tested. The competitive bindinug inhibitor (Sarl, Ala8)AII displayed the samiie binding-inhibition potency as that of All (Table IV) . In vitro studies (f 1251-AII biniditng to GBM exposed to anti-GBM antibodies. Binding of anti-GBM antibodies to GBM preparation after a 30-min incubation and extensive washing was always detectable by immunofluorescence whereas there was no binding with IgG fraction obtained from normal rabbits. Binding of 1251-AII to GBM as a function of 125I-AII concentration in the milieu was clearly diminished when GBM had been previously exposed to anti-GBM antibodies (Fig. 4b) . The decrease was about 50% at the lower concentrations tested and was observed whatever the concentration of hormone. Apparent KD values estimated as the concentrations corresponding to 50% of the apparent plateaus were similar with both preparations. On the contrary the number of sites calculated roughly from the amount of AII bound at each of these plateaus was clearly diminished after incubation with anti-GBM antibodies.
In vivo binding studies. Proteinuria and plasma creatinine were measured both in the experimental and in the control groups just before removing the kidneys. There was no difference in plasma creatinine (5.6+0.33 and 5.2+0.47 mg/liter in these two groups, respectively) whereas proteinuria was marked in the immunized rats (7.59+1.00 g/liter) and slight in the controls (0.33±+0.07 g/liter). Immunofluorescence studies showed the linear deposition of anti-GBM antibodies along GBM in kidney sections as well as in the final preparation of isolated glomeruli (Fig. la) .
Electron micrograplhs of kidney sections (Fig. lb) from animals injected with peroxidase-conjugated antibodies confirmed the presence of intense peroxidase activity throughout the GBM. Labeling was not detected on the endothelial or epithelial cells.
Binding of 1251-AII to the glomeruli isolated from immunized rats was markedly decreased. In timecourse studies, the plateau was much lower reaching approximately 30% of that observed with the control preparation. The two dissociation curves were parallel (Fig. 6) . Binding was also measured as a function of 1251-AII concentration in the milieu. At any concentration binding was clearly lower with the glomeruli isolated from immunized rats (Fig. 7) . Indexes of binding were calculated from the time-course studies as stated above. The affinity of the binding sites for All was one order of magnitude less with the preparation of immunized rats than with that of control rats (KD= 2.21+0.27 x 10-10 M and 4.15±0.57 x 10-"1 m in these two preparations, respectively).
Spontaneous degradatiotn of 1251-AII. Degradation of 1251-AII in the presence of either isolated glomeruli or GBM was measured with polyacrylamide gel electrophoresis and binding to an excess of specific antibodies. There was a progressive inactivation of the tracer as a function of time in the presence of isolated glomeruli whereas there was no change in the fraction of intact hormone between 5 and 15 min in the presence of GBM. Table V shows that after a 5-min incubation, there was more intact hormone in the preparation of isolated glomeruli whereas after a 15-min incubation there was more intact hormone in the preparation of GBM. The difference at any time was small, always less than 15%. This small difference could not account for the increase in binding observed with GBM. Similarly there was no difference between the rates of degradation of 125I-AII in the presence of glomeruli isolated from either control or immunized rats. In both cases, the amount of degraded hormone estimated as the percentage bound to an excess of specific antibody did not exceed 20% after a 15-min incubation.
Nature of the binding sites. To the membrane which subsequently alters the All-binding site interaction. These two possibilities might intervene simultaneously. In the "in vivo" experiments, the decrease in binding of All was greater than in the "in vitro" studies, approxiBinding of '25I-Angiotensin II to Rat Glomerular Basement Membranes mately 70% and there was also a lower affinity of AII for its binding sites whereas in the "in vitro" experiments affinity was unchanged. The binding of anti-GBM antibodies to GBM was probably the initial step of an inflammatory process which accounts for the supplementary decrease in the number of AII binding sites and for the change of affinity. There are some examples in the literature of the interaction of antibody with specific hormone receptors located on the cell surface (21, 22) . In the present study, the antibodies used were directed against unknown antigens of GBM and not against the specific receptors for AII themselves. In spite of this, rats passively immunized with anti-GBM antibodies can be considered as a model of "receptor disease" and used to determine the physiological significance of these receptors.
To our knowledge, the demonstration of high affinity specific binding sites for All in GBM is the first example of localization of such binding sites for a polypeptide hormone in a noncellular structure since usually these sites are only present on the cell surface. It could theoretically be possible that All did not bind to a constituent of GBM itself but to a plasma contaminant trapped in GBM since it has been previously shown that preparations of GBM might contain in significant amounts some plasma glycoproteins (19) . This hypothesis seems unlikely because the affinity of most hormones to plasma protein is much lower than their affinity to specific cell receptors (23) . AII has been shown to bind to human plasma protein but only in 5% of the subjects tested (24) . Although complete chemical characterization of the binding sites is not available, some information can be drawn from the influence on binding of various enzymes. The loss of 1251-AII binding after the treatment of GBM with trypsin suggested that this binding site was a protein. The marked increase in binding produced by collagenase indicated that the binding sites were not localized in the collagenous fraction of the GBM but rather in the glycoprotein moiety and were made more accessible after collagenase digestion. The slight decrease in binding produced by neuraminidase further suggested that sialic acid may be a part, probably not essential, of the binding protein.
In summary, the present studies have shown that AII can bind specifically and with a high affinity to the glycoprotein moiety of the GBM. We have no evidence to demonstrate that the binding sites involved in this reaction are real receptors mediating a subsequent physiological event. However, since GBM is the main barrier to glomerular filtration, it can be suggested that interaction of All with GBM may be the first event in a change in glomerular permeability induced by AII postulated in recent works with micropuncture data (6, 7) or clearance studies (25) .
